November 17, 2025
1 min read

CSL charts US plasma manufacturing expansion with $1.5B investment

The company will spend approximately $1.5 billion in capital investments to grow its U.S. plasma-based manufacturing capabilities over the next five years.

Leave a Reply

Your email address will not be published.

Previous Story

Cheetos & Doritos Get Dye-Free Makeover With New ‘Simply NKD’ Line

Next Story

Tufts expands Master’s programs in Public Health and Nutrition

Previous Story

Cheetos & Doritos Get Dye-Free Makeover With New ‘Simply NKD’ Line

Next Story

Tufts expands Master’s programs in Public Health and Nutrition

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop